
uarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on t
当前文章:http://eo7c1ge.muluqi.cn/dck64fg/281.html
发布时间:15:00:19
新闻热点
新闻爆料
图片精选
点击排行